Profile
Steffen Heeger is Chief Medical Officer at Actinium Pharmaceuticals, Inc. since 2026.
Former positions include Head-Clinical Development at MorphoSys AG, Head-Medical Affairs at Merck Serono SA, Chief Medical Officer at Ryvu Therapeutics SA, and Chief Medical Officer at Shanghai Full-Life Technologies Co., Ltd. Education includes a doctorate from Ruprecht-Karls-Universität Heidelberg.
Steffen Heeger active positions
| Companies | Position | Start |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2026-05-31 |
Former positions of Steffen Heeger
| Companies | Position | End |
|---|---|---|
Shanghai Full-Life Technologies Co. Ltd.
Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients | Chief Tech/Sci/R&D Officer | - |
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | - |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Corporate Officer/Principal | - |
| MORPHOSYS AG | Corporate Officer/Principal | - |
Training of Steffen Heeger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
MorphoSys AG
MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Ruprecht-Karls-Universität Heidelberg
Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono SA
Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism | Health Technology |
Ryvu Therapeutics SA
Ryvu Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops and sells therapies for precision oncology | Health Technology |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Shanghai Full-Life Technologies Co. Ltd.
Shanghai Full-Life Technologies Co. Ltd. BiotechnologyHealth Technology Engages in radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients | Health Technology |
- Stock Market
- Insiders
- Steffen Heeger
















